Literature DB >> 2993368

Muscarinic receptors on intact human fibroblasts. Absence of receptor activity in adult skin cells.

D A Van Riper, M P Absher, R H Lenox.   

Abstract

The intact human fibroblast has been used in clinical and basic research studies of receptor-mediated control of cell function, however there is little information about the relationship between muscarinic receptor density and the regulation of cyclic AMP (cAMP) accumulation. We have compared the muscarinic receptor characteristics of both lung and skin intact fibroblasts at fetal and adult stages of development using carbachol-mediated inhibition of cAMP accumulation and the binding of [3H]quinuclidinyl benzilate (QNB). Prostaglandin E1 (PGE1) stimulated cAMP accumulation in all four cell lines, while carbachol inhibited cAMP accumulation only in the fetal lung, adult lung, and to a lesser extent, the fetal skin. Adult skin fibroblasts did not display significant evidence of inhibitory muscarinic receptor activity. [3H]QNB binding was saturable for the fetal and adult lung, and the fetal skin, yielding Kd values of approximately 0.5 nM for these cell lines. Bmax values were 360 fmol/mg for fetal skin, 600 fmol/mg for adult lung, and 876 fmol/mg for the fetal lung. Specific binding of [3H]QNB to adult skin fibroblasts was found to be low and variable. Comparisons of the Bmax values and maximal inhibitory capacities showed that the receptor density paralleled receptor activity in all cell lines. The lack of muscarinic receptor activity in the adult skin fibroblast was confirmed in several different adult skin cell lines, indicating that the adult skin fibroblast may not be an appropriate model for muscarinic receptor activity in clinical investigations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993368      PMCID: PMC423924          DOI: 10.1172/JCI112047

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

Review 1.  Adenylate cyclase assay.

Authors:  Y Salomon
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

2.  Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.

Authors:  R H Lenox; J Ellis; D Van Riper; Y H Ehrlich
Journal:  Mol Pharmacol       Date:  1985-01       Impact factor: 4.436

3.  Decreased cAMP levels in human diploid cells exposed to cholinergic stimuli.

Authors:  R W Butcher
Journal:  J Cyclic Nucleotide Res       Date:  1978-12

4.  Comparison of the muscarinic-cholinergic and lysophosphatidate inhibition of fibroblast adenylate cyclase demonstrating desensitization to the cholinergic stimulus.

Authors:  D A Green; R B Clark
Journal:  Life Sci       Date:  1981-10-19       Impact factor: 5.037

5.  Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein.

Authors:  H R Bourne; H R Kaslow; A S Brickman; Z Farfel
Journal:  J Clin Endocrinol Metab       Date:  1981-09       Impact factor: 5.958

6.  Developmental loss of a smooth muscle muscarinic receptor population.

Authors:  M F Crouch; C P Morris; T B Cheah; R A Rush
Journal:  Brain Res       Date:  1982-01-28       Impact factor: 3.252

7.  Monoamine oxidase activity in normal and Lesch-Nyhan fibroblasts.

Authors:  S B Edelstein; C M Castiglione; X O Breakfield
Journal:  J Neurochem       Date:  1978-11       Impact factor: 5.372

8.  Phosphatidic acid inhibition of PGE1-stimulated cAMP accumulation in WI-38 fibroblasts: similarities with carbachol inhibition.

Authors:  R B Clark; D M Salmon; T W Honeyman
Journal:  J Cyclic Nucleotide Res       Date:  1980

9.  High-affinity [3H]choline accumulation in cultured human skin fibroblasts.

Authors:  D K Riker; R H Roth; X O Breakefield
Journal:  J Neurochem       Date:  1981-02       Impact factor: 5.372

10.  Altered nerve growth factor in fibroblasts from patients with familial dysautonomia.

Authors:  J P Schwartz; X O Breakefield
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

View more
  3 in total

1.  Modulation of muscarinic-receptor expression in human embryonic lung fibroblasts by platelet-derived growth factor.

Authors:  A Koman; O Durieu-Trautmann; P O Couraud; A D Strosberg; B B Weksler
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

2.  Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.

Authors:  Gregory D Scott; Allison D Fryer
Journal:  Chem Immunol Allergy       Date:  2012-06-26

Review 3.  Pulmonary fibroblasts, an emerging target for anti-obstructive drugs.

Authors:  Kurt Racké; Susanne Haag; Amit Bahulayan; Mareille Warnken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-13       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.